Noninsulin Antidiabetic Drugs for Patients with Type 2 Diabetes Mellitus: Are We Respecting Their Contraindications?

Figure 1

NIADs prescribed (alone or in combination) stratified by disease stage in patients with some degree of renal failure (GFR < 60 mL/min) (percentages are calculated for the total number of patients in each stage). AGI: alpha-glucosidase inhibitors; GLP-1ra: glucagon-like peptide-1 (GLP-1) receptor agonists; GFR: glomerular filtration rate; DPP4i: dipeptidyl peptidase-4 (DPP-4) inhibitors; NIAD: noninsulin antidiabetic drugs.